Atlas Trials

Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects with Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT05266950 · WITHDRAWN

Trial details

NCT number
NCT05266950
Sponsor
Beijing Boren Hospital
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2021-12-13
Primary completion
2023-12-12
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.